Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation

Biochemical Journal

Volumn 421, Issue 1, 2009, Pages 17-27

  Sato, Hiroyasu ^a,b   Taketomi, Yoshitaka ^a,b   Isogai, Yuki ^c   Masuda, Seiko ^a,b   Kobayashi, Tetsuyuki ^c   Yamamoto, Kei ^a   Murakami, Makoto ^a,d  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c OCHANOMIZU UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Dermatitis; Phospholipase A2; Phospholipid; Prostaglandin; Splenomegaly; Transgenic mouse

Indexed keywords

BEE VENOM; CHEMOKINES; ELEVATED LEVEL; GROUP III; INFLAMMATORY CYTOKINES; MOUSE SKIN; OVER-EXPRESSION; PHOSPHOLIPASE A; PHOSPHOLIPASE A2; PROSTAGLANDIN; PROSTAGLANDINE; SEBACEOUS GLAND; SPLENOMEGALY; SPONTANEOUS DEVELOPMENT; TRANSGENIC; TRANSGENIC MICE; TRANSGENIC MOUSE;

BODY FLUIDS; MACROPHAGES; MAMMALS; PATHOLOGY; PHOSPHOLIPIDS; SKIN;

PLANTS (BOTANY);

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN G1; PHOSPHOLIPASE A2 GROUP III; PROSTAGLANDIN E2; PLA2G3 PROTEIN, HUMAN; PLA2G3 PROTEIN, MOUSE;

ACANTHOSIS; AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DERMATITIS; ENZYME RELEASE; EROSION; EXTRAMEDULLARY HEMATOPOIESIS; GENE OVEREXPRESSION; GRANULOCYTOSIS; HYPERKERATOSIS; MACROPHAGE; MAMMAL; MONOCYTOSIS; MOUSE; MUCUS SECRETION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAKERATOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEBACEOUS GLAND DISEASE; SIALOADENITIS; SKIN INFLAMMATION; SKIN ULCER; SPLENOMEGALY; TRANSGENIC MOUSE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

APOIDEA; MAMMALIA; MUS; MUS MUSCULUS;

ANIMALS; DERMATITIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROUP III PHOSPHOLIPASES A2; INFLAMMATION; MICE; MICE, TRANSGENIC; SKIN;

EID: 67650315458     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20082429     Document Type: Article

References (43)

1. 2s. Adv. Immunol. 77, 163-194
2. 2 enzymes. Prostaglandins Other Lipid Mediat. 68-69, 3-58
3. 2. Annu. Rev. Biochem. 77, 495-520
4. 2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate. J. Clin. Invest. 97, 2233-2241
5. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J. Biol. Chem. 279 16488-16494
6. 2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J. Immunol. 179, 4800-4807
7. 2-deficient mice. Circulation 117, 2977-2985
8. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J. Exp. Med. 204, 865-877
9. 2 against Staphylococcus aureus. J. Immunol. 162, 7402-7408
10. 2. Arterioscler. Thromb. Vasc. Biol. 19, 1284-1290
11. 2 in mice leads to neonatal lethality because of lung dysfunction. J. Biol. Chem. 281, 36420-36433
12. 2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J. Biol. Chem. 283, 21640-21648
13. 2 with homology to the group III bee venom enzyme. J. Biol. Chem. 275, 7492-7496
14. 2s (group III and XII). J. Biol. Chem. 278, 10657-10667
15. 2. J. Biol. Chem. 280, 24987-24998
16. 2 transgenic mice reveals potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J. Biol. Chem. 283, 33483-33497
17. Bligh, E. G. and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification. J. Biochem. Physiol. 37, 911-917
18. Ghosh, A. K., Hirasawa, N., Ohtsu, H., Watanabe, T. and Ohuchi, K. (2002) Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J. Exp. Med. 195, 973-982
19. 2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792
20. 2 in allergic response and parturition. Nature 390, 618-622
21. Min-induced intestinal neoplasia. Cell 81, 957-966
22. 2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis. Oncogene 22, 1936-1944
23. 2s in regulating arachidonic acid release and prostaglandin generation. J. Biol. Chem. 274, 31435-31444
24. 2. J. Biol. Chem. 280, 23203-23214
25. 2 receptor EP2 results in enhanced skin tumor development. Oncogene 25, 5507-5516
26. 2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J. Biol. Chem. 281, 6691-6698
27. 2 involved in arachidonic acid mobilization in murine P388D1 macrophages. J. Biol. Chem. 271, 32381-32384
28. 2 and cyclooxygenase-2 in activated human keratinocytes. Am. J. Physiol. Cell. Physiol. 278, C822-C833
29. 2 is expressed in human colon carcinoma cells and human mast cells and upregulated in mouse inflammatory tissues. Eur. J. Biochem. 269, 2698-2707
30. 2 in human keratinocytes and in healthy and psoriatic human skin. J. Invest. Dermatol. 124, 204-211
31. Zabalawi, M., Bhat, S., Loughlin, T., Thomas, M. J., Alexander, E., Cline, M., Bullock, B., Willingham, M. and Sorci-Thomas, M. G. (2003) Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol. Am. J. Pathol. 163, 1201-1213
32. -/- mice: Link between cholesterol homeostasis and self-tolerance? J. Lipid Res. 48 52-65
33. Jong, M. C., Gijbels, M. J., Dahlmans, V. E., Gorp, P. J., Koopman, S. J., Ponec, M., Hofker, M. H. and Havekes, L. M. (1998) Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J. Clin. Invest. 101, 145-152
34. Cockerill, G. W., Huehns, T. Y., Weerasinghe, A., Stocker, C., Lerch, P. G., Miller, N. E. and Haskard, D. O. (2001) Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 103, 108-112
35. Weserberg, R., Tvrdik, P., Undén, A.-B., Månsson, J.-E., Norlén, L., Jakobsson, A., Holleran, W. H., Elias, P. M., Asadi, A., Flodby, P. et al. (2004) Role for ELOVL3 and fatty acid chain length in development of hair and skin function. J. Biol. Chem. 279, 5621-5629
36. Zheng, Y., Eilertsen, K. J., Ge, L., Zhang, L., Sundberg, J. P., Prouty, S. M., Stenn, K. S. and Parimoo, S. (1999) Scd1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat. Genet. 23 268-270
37. Stone, S. J., Myers, H. M., Watkins, S. M., Brown, B. E., Feingold, K. R., Elias, P. M. and Farese, Jr, R. V. (2004) Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279, 11767-11776
38. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874
39. 2 promotes neuronal outgrowth and survival. Biochem. J. 409, 429-438
40. 2-III as a biomarker candidate. Br. J. Cancer 98, 587-595
41. 2 induces dendritic cell maturation. Eur. J. Immunol. 34, 2293-2302
42. 2s act on distinct cellular phospholipids molecular species. Biochim. Biophys. Acta 1771, 1389-1396
43. 2 involved in N-type receptor binding and neurotoxicity. J. Biol. Chem. 272, 7173-7181